Clinical Trials Logo
  1. Home
  2. Vestibular Migraine
  3. NCT05396482
  4. Details
NCT05396482 Clinical Trial

Assesment of Hearing in Patients With Vestibular Migra

Vestibular Migraine Clinical Trial

Official title:
Assesment of Hearing in Patients With Vestibular Migraine

Clinical Trial Details — Status: Enrolling by invitation

Administrative data
NCT number NCT05396482
Other study ID # Rahma93
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date May 18, 2023

Study information
Verified date May 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Evaluation of hearing in patients with vestibular migraine

Recruitment information / eligibility
Status Enrolling by invitation
Enrollment 25
Est. completion date May 18, 2023
Est. primary completion date May 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - vertigo Exclusion Criteria: - hypertension

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Pure tone audiometer
Pure tone audiometer

Locations
Country Name City State
Egypt Assiut University Assiut

Sponsors (1)
Lead Sponsor Collaborator
Rahma Alaa Kamel

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Pathology For vestibular migraine 2 years
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Recruiting NCT04417361 - Galcanezumab for Vestibular Migraine Phase 2
Completed NCT03979677 - Effects of Lifestyle Modification on Vestibular Migraine N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Not yet recruiting NCT05914207 - Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent N/A
Enrolling by invitation NCT06417684 - Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine Early Phase 1
Recruiting NCT04939922 - China Headache Registry Study
Recruiting NCT05472675 - Local Sensory Nerve Block in the Treatment of Vestibular Migraine N/A
Recruiting NCT05418218 - International Headache Registry Study
Suspended NCT04026516 - CAVA: Dizziness Trial N/A
Withdrawn NCT03578354 - 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine Phase 2
Completed NCT02350985 - Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine Phase 4
Completed NCT03417596 - Vestibular Rehabilitation in Patients With Vestibular Migraine N/A
Not yet recruiting NCT04664088 - Acupuncture for Prophylaxis of Vestibular Migraine N/A
Enrolling by invitation NCT06267924 - SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines N/A
Completed NCT05960786 - Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand N/A
Completed NCT02447991 - Rizatriptan for Episodic Dizziness in Vestibular Migraine Phase 2/Phase 3
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Not yet recruiting NCT05508139 - The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients
Completed NCT01669304 - Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness Phase 1